Mo; Shifu
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mo; Shifu.The latest application filed is for "anti-ceacam5 monoclonal antibody and preparation method thereof and use thereof".
- Mo; Shifu - Nanjing CN
- MO; Shifu - SHANGHAI CN
| Patent | Date |
|---|---|
| Anti-OX40 antibody Grant 11,440,965 - Mo , et al. September 13, 2 | 2022-09-13 |
| Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof App 20220242968 - MO; Shifu ; et al. | 2022-08-04 |
| Anti-ceacam5 Monoclonal Antibody, Preparation Method Thereof And Use Thereof App 20220235142 - Mo; Shifu ; et al. | 2022-07-28 |
| Isolated Antibody Or Antigen Binding Fragment Thereof And Use Of Same In Tumor Treatment App 20210269539 - Mo; Shifu ; et al. | 2021-09-02 |
| Fusion Protein And Its Applicaton In Preparing Medicine For Treating Tumor And/or Viral Infection App 20210198375 - Mo; Shifu ; et al. | 2021-07-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 